Skip to content
naulon

Not checkedNot checked for notices yet.

Molecular markers associated with outcome and metastasis in human pancreatic cancer

Van den Broeck Anke, Vankelecom Hugo, Van Eijsden Rudy and 2 more

Journal of Experimental & Clinical Cancer Research · 2012

doi:10.1186/1756-9966-31-68 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous cancer in which differences in survival rates might be related to a variety in gene expression profiles. Although the molecular biology of PDAC begins to be revealed, genes or pathways that specifically drive tumour progression or metastasis are not well understood.</p> <p>Methods</p> <p>We performed microarray analyses on whole-tumour samples of 2 human PDAC subpopulations with similar clinicopathological features, but extremely distinct survival rates after potentially curative surgery, i.e. good outcome (OS and DFS > 50 months, n = 7) <it>versus</it> bad outcome (OS < 19 months and DFS < 7 months, n = 10). Additionally, liver- and peritoneal metastases were analysed and compared to primary cancer tissue (n = 11).</p> <p>Results</p> <p>The integrin and ephrin receptor families were upregulated in all PDAC samples, irrespective of outcome, supporting an important role of the interaction between pancreatic cancer cells and the surrounding desmoplastic reaction in tumorigenesis and cancer progression. Moreover, some components such as <it>ITGB1</it> and <it>EPHA2</it> were upregulated in PDAC samples with a poor outcome, Additionally, overexpression of the non-canonical Wnt/β-catenin pathway and EMT genes in PDAC samples with bad <it>versus</it> good outcome suggests their contribution to the invasiveness of pancreatic cancer, with <it>β-catenin</it> being also highly upregulated in metastatic tissue.</p> <p>Conclusions</p> <p>Components of the integrin and ephrin pathways and EMT related genes, might serve as molecular markers in pancreatic cancer as their expression seems to be related with prognosis.</p>

Abstract licence: CC BY

Cited by papers we hold2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.